162 related articles for article (PubMed ID: 28109117)
1. Lipid profiling of parkin-mutant human skin fibroblasts.
Lobasso S; Tanzarella P; Vergara D; Maffia M; Cocco T; Corcelli A
J Cell Physiol; 2017 Dec; 232(12):3540-3551. PubMed ID: 28109117
[TBL] [Abstract][Full Text] [Related]
2. Searching for Potential Lipid Biomarkers of Parkinson's Disease in Parkin-Mutant Human Skin Fibroblasts by HILIC-ESI-MS/MS: Preliminary Findings.
Calvano CD; Ventura G; Sardanelli AMM; Savino L; Losito I; Michele G; Palmisano F; Cataldi TRI
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284683
[TBL] [Abstract][Full Text] [Related]
3. Decreased amount of vimentin N-terminal truncated proteolytic products in parkin-mutant skin fibroblasts.
Siciliano RA; Mazzeo MF; Ferretta A; Pacelli C; Rosato A; Papa F; Scacco S; Papa S; Cocco T; Lippolis R
Biochem Biophys Res Commun; 2020 Jan; 521(3):693-698. PubMed ID: 31699368
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial impairment observed in fibroblasts from South African Parkinson's disease patients with parkin mutations.
van der Merwe C; Loos B; Swart C; Kinnear C; Henning F; van der Merwe L; Pillay K; Muller N; Zaharie D; Engelbrecht L; Carr J; Bardien S
Biochem Biophys Res Commun; 2014 May; 447(2):334-40. PubMed ID: 24721425
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations.
González-Casacuberta I; Juárez-Flores DL; Ezquerra M; Fucho R; Catalán-García M; Guitart-Mampel M; Tobías E; García-Ruiz C; Fernández-Checa JC; Tolosa E; Martí MJ; Grau JM; Fernández-Santiago R; Cardellach F; Morén C; Garrabou G
Aging (Albany NY); 2019 Jun; 11(11):3750-3767. PubMed ID: 31180333
[TBL] [Abstract][Full Text] [Related]
6. Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients.
Rakovic A; Grünewald A; Seibler P; Ramirez A; Kock N; Orolicki S; Lohmann K; Klein C
Hum Mol Genet; 2010 Aug; 19(16):3124-37. PubMed ID: 20508036
[TBL] [Abstract][Full Text] [Related]
7. Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches.
Ozgul S; Kasap M; Akpinar G; Kanli A; Güzel N; Karaosmanoglu K; Baykal AT; Iseri P
Neurochem Int; 2015; 85-86():1-13. PubMed ID: 25865804
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.
González-Casacuberta I; Morén C; Juárez-Flores DL; Esteve-Codina A; Sierra C; Catalán-García M; Guitart-Mampel M; Tobías E; Milisenda JC; Pont-Sunyer C; Martí MJ; Cardellach F; Tolosa E; Artuch R; Ezquerra M; Fernández-Santiago R; Garrabou G
Neurobiol Aging; 2018 May; 65():206-216. PubMed ID: 29501959
[TBL] [Abstract][Full Text] [Related]
9. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
10. Cytoskeletal Alterations and Biomechanical Properties of parkin-Mutant Human Primary Fibroblasts.
Vergara D; Ferraro MM; Cascione M; del Mercato LL; Leporatti S; Ferretta A; Tanzarella P; Pacelli C; Santino A; Maffia M; Cocco T; Rinaldi R; Gaballo A
Cell Biochem Biophys; 2015 Apr; 71(3):1395-404. PubMed ID: 25399302
[TBL] [Abstract][Full Text] [Related]
11. Design and high-throughput implementation of MALDI-TOF/MS-based assays for Parkin E3 ligase activity.
Traynor R; Moran J; Stevens M; Antico O; Knebel A; Behrouz B; Merchant K; Hastie CJ; Davies P; Muqit MMK; De Cesare V
Cell Rep Methods; 2024 Feb; 4(2):100712. PubMed ID: 38382522
[TBL] [Abstract][Full Text] [Related]
12. Mutant Parkin impairs mitochondrial function and morphology in human fibroblasts.
Grünewald A; Voges L; Rakovic A; Kasten M; Vandebona H; Hemmelmann C; Lohmann K; Orolicki S; Ramirez A; Schapira AH; Pramstaller PP; Sue CM; Klein C
PLoS One; 2010 Sep; 5(9):e12962. PubMed ID: 20885945
[TBL] [Abstract][Full Text] [Related]
13. In search for mitochondrial biomarkers of Parkinson's disease: Findings in parkin-mutant human fibroblasts.
Kamienieva I; Charzyńska A; Duszyński J; Malińska D; Szczepanowska J
Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166787. PubMed ID: 37302428
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol Modulation of Protein Expression in
Vergara D; Gaballo A; Signorile A; Ferretta A; Tanzarella P; Pacelli C; Di Paola M; Cocco T; Maffia M
Oxid Med Cell Longev; 2017; 2017():2198243. PubMed ID: 29138676
[TBL] [Abstract][Full Text] [Related]
15. New approach for glyco- and lipidomics--molecular scanning of human brain gangliosides by TLC-Blot and MALDI-QIT-TOF MS.
Valdes-Gonzalez T; Goto-Inoue N; Hirano W; Ishiyama H; Hayasaka T; Setou M; Taki T
J Neurochem; 2011 Mar; 116(5):678-83. PubMed ID: 21244424
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic variability of parkin mutations in single kindred.
Koentjoro B; Park JS; Ha AD; Sue CM
Mov Disord; 2012 Sep; 27(10):1299-303. PubMed ID: 22807239
[TBL] [Abstract][Full Text] [Related]
17. Loss of parkin promotes lipid rafts-dependent endocytosis through accumulating caveolin-1: implications for Parkinson's disease.
Cha SH; Choi YR; Heo CH; Kang SJ; Joe EH; Jou I; Kim HM; Park SM
Mol Neurodegener; 2015 Dec; 10():63. PubMed ID: 26627850
[TBL] [Abstract][Full Text] [Related]
18. Progress in detection and structural characterization of glycosphingolipids in crude lipid extracts by enzymatic phospholipid disintegration combined with thin-layer chromatography immunodetection and IR-MALDI mass spectrometry.
Kouzel IU; Pirkl A; Pohlentz G; Soltwisch J; Dreisewerd K; Karch H; Müthing J
Anal Chem; 2014 Jan; 86(2):1215-22. PubMed ID: 24386974
[TBL] [Abstract][Full Text] [Related]
19. Phospholipids and glycosphingolipids in cultured skin fibroblasts from patients with progressive systemic sclerosis (scleroderma).
Komleva AV; Prokazova NV; Gabrielyan ND; Mukhin DN; Kashnikova LN; Zvezdina ND; Martinova LE; Panasyuk AF
Clin Exp Rheumatol; 1995; 13(5):581-8. PubMed ID: 8575135
[TBL] [Abstract][Full Text] [Related]
20. A direct and simple method of coupling matrix-assisted laser desorption and ionization time-of-flight mass spectrometry (MALDI-TOF MS) to thin-layer chromatography (TLC) for the analysis of phospholipids from egg yolk.
Fuchs B; Schiller J; Süss R; Schürenberg M; Suckau D
Anal Bioanal Chem; 2007 Oct; 389(3):827-34. PubMed ID: 17673987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
